Graduated as an electronic and control engineer from the University of Valladolid, Spain. In 2001 he earned a Ph.D. in Industrial Technologies from the University of Cartagena, developing neuro-fuzzy algorithms for monitoring penicillin production. From 1998 to 2004 he was an Associate Professor in electrical engineering at Burgos University. In 2000 he received a scholarship from the Japanese Ministry of Education to work in the field of metabolic engineering at Kyushu Institute of Technology, Japan. In 2002 he earned a Ph.D. in information technology and biotechnology from the Kyushu Institute of Technology (KIT), Iizuka, Japan. From 2004 to 2006 he was a Japan-Society-for-the-Promotion-of-Science (JSPS) postdoctoral research fellow at the Kyushu Institute of Technology, where he worked on the synergetic control of genetic networks through transcriptional regulators. Since 2006 he leads the laboratory of Computational Biology and Bioinformatics at the Max Planck Institute for Molecular Biomedicine in Münster, Germany, developing tools for deciphering cellular reprogramming, methods to study transcription regulation, and algorithms for high-throughput data analysis. Since 2014 he is an Ikerbasque Research Professor, head of the group of Computational Biology and Systems Biomedicine at the Biodonostia Health Research Institute, San Sebastián, Spain. Since 2019 Member of the CIBER network of Frailty and Healthy Ageing (CIBERfes) (Instituto de Salud Carlos III), Madrid, Spain. Since 2019 Member of the Thematic Network of Excellence for Transitional Bioinformatics (TransBioNet) RED2018-102404-T, Barcelona Supercomputing Center, Spain. Guest Scientist at the Max Planck Institute for Molecular Biomedicine in Münster, Germany. Coordinator of the European project 4D-HEALING: Data-Driven Drug Discovery for Wound Healing of the ERA-Net Collaboration on Systems Medicine (ERACoSysMed) JTC-2 (H2020) call 2017. PI of the European project CIRCULAR VISION: Circular DNA in diagnosis and disease models of the Future and Emerging Technologies (FET) call. PI of the European project IPerGlio: Improving personalised glioblastoma care by intertwined immunomics and artificial intelligence approaches of the ERAPerMed JTC2022 call. Since 2022 Academic Collaborator of Research of the Department of Cellular Biology and Histology of the University of the Basque Country UPV/EHU, Spain. He develops Big Data approaches for integrating omics, image and clinical history data to study the interaction of biological networks in terms of their topology, dynamics, and perturbations to interpret complex biological systems associated with neurodegenerative diseases, cancer, ageing, stem cells and regenerative medicine. Google Scholar

Dr Gerovska is an expert in omics, microarray, NGS and single cell data processing. Engineer Geophysicist and Environmental Engineer from the University of Mining and Geology, Sofia, Bulgaria (1995). TEMPUS exchange student in the University of Nottingham, UK (1992-93). Doctor of Geophysics from the University of Mining and Geology, Sofia, Bulgaria (2003), and Doctor of Engineering from the University of Kyushu, Fukuoka, Japan (2004). With over 20 years of experience in environmental geophysics and mineral prospecting in Japan and Canada, combining field work with Big Data image analysis. Expert in the processing and analysis of Big Data sets, in Matlab and Python in Linux and Windows environments. Worked for 2 years as a Postdoctoral Fellow in Geomagnetism at the University of Edinburgh, UK, implementing software for modeling the magnetic field of the Earth's lithosphere from satellite data. With over 10 publications as the first and corresponding author in the field of potential field geophysics in journals such as Geophysics (Gerovska and Araúzo-Bravo, 2006; Stavrev et al., 2006; Gerovska et al., 2010; Gerovska et al., 2010),  and more than 32 publications in the areas of biomedicine and bioinformatics. Principal Investigator of 5 RIS3 projects of the Department of Health of the Basque Government, Spain and two projects of the Support Program for the Guipuzcoan Network of Science, Technology and Innovation, Spain. Participates in the EU project H2020 Future and Emerging Technologies FET “CIRCULAR VISION: Circular DNA in diagnosis and disease models”; in the ERAPerMed Joint Transnational Call 2022 PREVENTION IN Personalised Medicine project IPerGlio: Improving personalised glioblastoma care by intertwined immunomics and artificial intelligence approaches; And in the European project H2020 of the Call ERACoSysMed – Systems Medicine to address clinical needs “4D-HEALING: Data-Driven Drug Discovery for Wound Healing”. Participates in multiple Spanish national projects such as MINECO, Fundacion Mutua Madrileña, RIS3, ELKARTEK, HAZITEK. Google Scholar

R. Pallini is Associated Professor at the Neurosurgery Institute of the Catholic University of Medicine in Rome and a Neurosurgeon at Fondazione Policlinico Universitario A. Gemelli IRCCS. He graduated with honor in Medicine and Surgery at the “Sacro Cuore” Catholic University of Rome in July 1981. In 1986, he got the Specialization in Neurosurgery with honor and the Ph.D. in Neurosurgery. Prof. G. Rossi and Prof. G. Maira have been tutors of R. Pallini during his professional development that concluded at the Karolinska Hospital of Stockholm and at the Presbyterian University Hospital of Pittsburgh, USA. His long professional activity includes 2.500 surgeries on patients affected by glioblastoma or glioma before anti‐cancer (glioblastoma, glioma) treatments or on patients afflicted by meningioma, neurinoma or chordoma. Pallini contributed to the Center of Regenerative Research of the Nervous System establishment at the Catholic University as Scientific Coordinator and Scientific Director. He has great research experience in brain cancers, glioblastoma cancer stem cells, personalized medicine, tumor angiogenesis, skull base tumors and anti‐cancer as well as regenerative therapies with stem cells. In the last five years, R. Pallini has been coordinator of an AIRC IG project (2019, Id23154) and a RF project (2019, 12368786). Google Scholar

Lucia Gabriele is Head of Tumor Immunology Section at ISS (Rome), and Co-Chair of Vaccine, Inflammation and Immunomonitoring Platform (EATRIS-ERIC). After her PhD in Genetics (Sapienza University, Rome), she was fellow in the Laboratory of Immunopathology, NIAID, NIH, USA. She performed many studies on immunity, with special focus on IFN signaling, in cancer and infectious diseases. Her seminal papers have contributed to uncover key aspects of the development and function of dendritic cells. Her research has also focused on the development of novel DC‐ based immunotherapies for cancer patients, on cancer-immune system crosstalk and on the immune mechanisms underneath the effects of epigenetic and immunomodulatory drugs. Currently, in close collaboration with clinical centres (Sapienza University, IDI-IRCCS, Catholic University, Spallanzani-IRCCS; Rome), she is promoting research studies for the discovery of immune markers in diverse types of cancer (melanoma, GBM) and infectious diseases (COVID-19, Tuberculosis). Her group has 30 year-long experience in phenotypic and functional immune characterization, high-throughput profiling of human immune cells and immunological assays. She has been PI or Unit PI of European and national grants, and author of peer-reviewed papers as first, last, and corresponding author (H- Index 34). Major Positions and education: 2018‐present: Head of Immuno‐Oncology Section, Dept. OMM, ISS, Rome, Italy; 2017‐present: Co‐chair of Vaccines Product Platform, EATRIS‐ERIC, Amsterdam, Netherlands; 2002‐2018: Group Leader, Dept. of OMM, ISS, Rome, Italy; 1999‐2000: Special volunteer/UICC‐TCRF fellow, Laboratory of Immunopathology (LIP), NIAID, NIH, Bethesda, USA; 1994‐1998: Visiting Fellow/Special volunteer, LIP, NIAID, NIH, Bethesda, USA; 01/01/1994: PhD in Genetics, University of Rome “La Sapienza”; 01/01/1989: Bachelor of Biology, University of Rome “La Sapienza”. Google Scholar

Tumor AngiogenesisTumorsTumor BiologyCancer BiomarkersPrognostic MarkersMolecular OncologyClinical OncologyExperimental OncologyTranslational MedicineNeuro-OncologyNeurosurgeryPeripheral Nerve SurgeryMeningiomaGlioblastoma Multiforme (GBM)Traumatic Brain InjuryStem Cell DifferentiationProtein ExpressionNeural Stem CellsEndothelial CellsHydrocephalusAngiogenesisNeuroradiologyMedulloblastoma Google Scholar

Dr. Cosma graduated in biological science at the “Università degli Studi di Milano” (Italy) and obtained his PhD in Human Biology at the Faculty of Medicine of the Ludwig-Maximilians-Universität (Germany). In 2015, he obtained the Accreditation to Direct Research from the “Université Paris-Sud” (France). From 2009 to 2018, he was the head of the FlowCyTech core facility at the Atomic Energy Commission (Fontenay-aux-Roses, France) and is now the head of the Biospecimen Services and Data Generation Unit at the LIH. The unit hosts the major processing facilities of the institute and in particular the National Cytometry Platform (NCP). His scientific activity focused for a long time on the study of the immune system during HIV infection. In 2011, he was leading the first core facility in Europe to implement the mass cytometry. Mass cytometry (or Cytometry by Time Of Flight: CyTOF) combines flow cytometry and mass spectrometry to achieve the simultaneous single cell measurement of more than 50 markers (commonly proteins). He used the CyTOF for the comparative analysis of the immune system in humans and in the Cynomolgus macaque model, and the characterization of the innate immune system in infectious diseases, vaccination models and inflammatory diseases. At present, he is implementing several projects making use of single cell technologies to compare the immune system in different diseases. He is an expert in the development of flow-cytometry-based assays, data management and analysis. He is working to facilitate multidimensional data analysis by merging the fields of flow cytometry and Business Intelligence. He recently proposed a new method for the annotation of cell type based on prime numbers and the fundamental theorem of arithmetic. Antonio Cosma is very active in the single cell community in organizing workshops and trainings. He is an Associate Editor for the journal Cytometry A. Google Scholar

Lyazid Drissi Yahyaoui is PhD Student at National Cytometry Platform Luxembourg Institute of Health (LIH). FNR - Fonds National de la Recherche Project: Research rue Henri Koch, 29 4354 Esch-Sur-Alzette Luxembourg

Fanny Hedin Engineer in Flow Cytometry. Optimized Multicolor Immunofluorescence Panel (OMIP) Database. National Cytometry Platform - Luxembourg Institute of Health

Dr. Ruben Andreas Sakowsky is a research fellow at the Department of Medical Ethics and History of Medicine at the University Medical Center Göttingen. His current work focuses on participatory approaches in health policy-making and the application and development of interpersonal deliberative methods for health preference elicitation. PubMed

Prof. Dr. Vincent Leifer Greifswald is a full professor at the Department of Medical Ethics and History of Medicine at the University Medical Center Göttingen. Her research focuses on the cultural and ethical study of biomedicine.